Gloria N. Akaluka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gloria N. Akaluka has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Abdelillah Soussi Gounni
Department of Immunology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
1 shared publication Aida Feiz-Barazandeh
Department of Immunology, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba R3E 0T5
1 shared publicationChidalu A Edechi
Department of Pathology, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba R3E 3P5
1 shared publication- Chukwunonso Onyilagha
National Centre for Foreign Animal Disease, Canadian Food Inspection Agency, Winnipeg, MB R3E 3M4, Canada
1 shared publication - Enitan S. Salako
Department of Immunology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada
1 shared publication - Jude Ezeh Uzonna
Department of Immunology, Max Rady College of Medicine, University of Manitoba
1 shared publication
Latest Publications
- 1 February 2021
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 206 (3) , 588-598
Semaphorin 3E Promotes Susceptibility to Leishmania major Infection in Mice by Suppressing CD4+ Th1 Cell Response
Protective immunity to cutaneous leishmaniasis is mediated by IFN-γ–secreting CD4+ Th1 cells. IFN-γ binds to its receptor on Leishmania-infected macrophages, resulting in their activation, production of NO, and subsequent destruction of parasites. This study investigated the role of Semaphorin 3E (Sema3E) in host immunity to Leishmania major infection in mice. We observed a significant increase in Sema3E expression at the infection site at different timepoints following L. major infection. Sema3E-deficient (Sema3E knockout [KO]) mice were highly resistant to L. major infection, as evidenced by significantly (p < 0.05–0.01) reduced lesion sizes and lower parasite burdens at different times postinfection when compared with their infected wild-type counterpart mice. The enhanced resistance of Sema3E KO mice was associated with significantly (p < 0.05) increased IFN-γ production by CD4+ T cells. CD11c+ cells from Sema3E KO mice displayed increased expression of costimulatory molecules and IL-12p40 production following L. major infection and were more efficient at inducing the differentiation of Leishmania-specific CD4+ T cells to Th1 cells than their wild-type counterpart cells. Furthermore, purified CD4+ T cells from Sema3E KO mice showed increased propensity to differentiate into Th1 cells in vitro, and this was significantly inhibited by the addition of recombinant Sema3E in vitro. These findings collectively show that Sema3E is a negative regulator of protective CD4+ Th1 immunity in mice infected with L. major and suggest that its neutralization may be a potential therapeutic option for treating individuals suffering from cutaneous leishmaniasis. Key Points Sema3E suppresses CD11C+ cells and T cell functions during L. major infection. The deficiency of Sema3E leads to enhanced resistance to L. major infection. Visual Abstract
- 1 February 2021
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 206 (3) , 588-598
Semaphorin 3E Promotes Susceptibility to Leishmania major Infection in Mice by Suppressing CD4+ Th1 Cell Response
Protective immunity to cutaneous leishmaniasis is mediated by IFN-γ–secreting CD4+ Th1 cells. IFN-γ binds to its receptor on Leishmania-infected macrophages, resulting in their activation, production of NO, and subsequent destruction of parasites. This study investigated the role of Semaphorin 3E (Sema3E) in host immunity to Leishmania major infection in mice. We observed a significant increase in Sema3E expression at the infection site at different timepoints following L. major infection. Sema3E-deficient (Sema3E knockout [KO]) mice were highly resistant to L. major infection, as evidenced by significantly (p < 0.05–0.01) reduced lesion sizes and lower parasite burdens at different times postinfection when compared with their infected wild-type counterpart mice. The enhanced resistance of Sema3E KO mice was associated with significantly (p < 0.05) increased IFN-γ production by CD4+ T cells. CD11c+ cells from Sema3E KO mice displayed increased expression of costimulatory molecules and IL-12p40 production following L. major infection and were more efficient at inducing the differentiation of Leishmania-specific CD4+ T cells to Th1 cells than their wild-type counterpart cells. Furthermore, purified CD4+ T cells from Sema3E KO mice showed increased propensity to differentiate into Th1 cells in vitro, and this was significantly inhibited by the addition of recombinant Sema3E in vitro. These findings collectively show that Sema3E is a negative regulator of protective CD4+ Th1 immunity in mice infected with L. major and suggest that its neutralization may be a potential therapeutic option for treating individuals suffering from cutaneous leishmaniasis. Key Points Sema3E suppresses CD11C+ cells and T cell functions during L. major infection. The deficiency of Sema3E leads to enhanced resistance to L. major infection. Visual Abstract